Literature DB >> 22633307

Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy.

Essa M Essa1, Michael R Zile, Robert E Stroud, Allison Rice, Richard J Gumina, Carl V Leier, Francis G Spinale.   

Abstract

BACKGROUND: Transient changes in the composition of the myocardial extracellular matrix may contribute to the ventricular systolic dysfunction in stress-induced cardiomyopathy (SIC). We examined the changes in plasma matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) that occur early after the clinical presentation of SIC. METHODS AND
RESULTS: Ten patients with SIC were enrolled. Plasma concentrations of the 6 major MMPs (1, 2, 3, 7, 8, and 9) and all 4 TIMPs (1, 2, 3, and 4) were analyzed and compared with data from 15 control subjects. Within 24 hours of the clinical presentation, SIC patients had lower MMP-1 levels (0.41 ± 0.13 vs 0.70 ± 0.13 pg/mL; P = .048) and MMP-8 levels (1.61 ± 0.34 vs 4.84 ± 1.38 pg/mL; P = .001) and higher TIMP-4 levels (3.06 ± 0.40 vs 2.16 ± 0.18 pg/mL; P = .05) compared with control. Seven of 9 SIC patients had elevated LV end-diastolic pressures, and all had normal LV end-diastolic dimensions and volumes.
CONCLUSIONS: Patients afflicted with SIC had MMP and TIMP profiles similar to those described in hypertensive heart disease and diastolic heart failure and different from the profiles following myocardial infarction. Our findings uncovered a unique biomolecular profile in SIC during the first 24 hours of presentation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22633307      PMCID: PMC3361732          DOI: 10.1016/j.cardfail.2012.04.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  48 in total

1.  Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment.

Authors:  Jason D Stroud; Catalin F Baicu; Mary A Barnes; Francis G Spinale; Michael R Zile
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

2.  Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences.

Authors:  Khaled Alfakih; Sven Plein; Holger Thiele; Tim Jones; John P Ridgway; Mohan U Sivananthan
Journal:  J Magn Reson Imaging       Date:  2003-03       Impact factor: 4.813

3.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

4.  High-dose norepinephrine induces disruption of myocardial extracellular matrix and left ventricular dilatation and dysfunction in a novel feline model.

Authors:  Yung-Tsung Chiu; Ching-Chang Cheng; Nai-Nu Lin; Yi-Wen Hung; Ying-Tsung Chen; Shih-Lan Hsu; Ching-Shiang Chi; Yun-Ching Fu
Journal:  J Chin Med Assoc       Date:  2006-08       Impact factor: 2.743

5.  Cardiac remodeling after long term norepinephrine treatment in rats.

Authors:  W Briest; A Hölzl; B Rassler; A Deten; M Leicht; H A Baba; H G Zimmer
Journal:  Cardiovasc Res       Date:  2001-11       Impact factor: 10.787

6.  Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload.

Authors:  Amanda L Chancey; Gregory L Brower; J Thomas Peterson; Joseph S Janicki
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

7.  Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.

Authors:  Carson S Webb; David D Bonnema; S Hinan Ahmed; Amy H Leonardi; Catherine D McClure; Leslie L Clark; Robert E Stroud; William C Corn; Laura Finklea; Michael R Zile; Francis G Spinale
Journal:  Circulation       Date:  2006-08-21       Impact factor: 29.690

8.  Disruption of the myocardial extracellular matrix leads to cardiac dysfunction.

Authors:  H E Kim; S S Dalal; E Young; M J Legato; M L Weisfeldt; J D'Armiento
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

9.  Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats.

Authors:  Michael J Cox; Harpreet S Sood; Matthew J Hunt; Derrick Chandler; Jeffrey R Henegar; Giorgio M Aru; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

10.  Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

Authors:  Ramón Martos; John Baugh; Mark Ledwidge; Christina O'Loughlin; Carmel Conlon; Anil Patle; Seamas C Donnelly; Kenneth McDonald
Journal:  Circulation       Date:  2007-02-05       Impact factor: 29.690

View more
  7 in total

1.  Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease.

Authors:  John S Ikonomidis; Charlotte R Ivey; Jason B Wheeler; Adam W Akerman; Allison Rice; Risha K Patel; Robert E Stroud; Asad A Shah; Chad G Hughes; Giovanni Ferrari; Rupak Mukherjee; Jeffrey A Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2013-01-11       Impact factor: 5.209

Review 2.  Membrane-associated matrix proteolysis and heart failure.

Authors:  Francis G Spinale; Joseph S Janicki; Michael R Zile
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

3.  Ensemble machine learning model identifies patients with HFpEF from matrix-related plasma biomarkers.

Authors:  Michael Ward; Amirreza Yeganegi; Catalin F Baicu; Amy D Bradshaw; Francis G Spinale; Michael R Zile; William J Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-11       Impact factor: 4.733

4.  Activation of Inflammatory and Pro-Thrombotic Pathways in Acute Stress Cardiomyopathy.

Authors:  Timothy P Fitzgibbons; Yvonne J K Edwards; Peter Shaw; Aline Iskandar; Mohamed Ahmed; Josiah Bote; Tejen Shah; Sumita Sinha; Robert E Gerszten; John F Keaney; Michael R Zile; Gerard P Aurigemma
Journal:  Front Cardiovasc Med       Date:  2017-08-03

5.  Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome.

Authors:  Olavi Parkkonen; Mikko T Nieminen; Paula Vesterinen; Taina Tervahartiala; Markus Perola; Veikko Salomaa; Pekka Jousilahti; Timo Sorsa; Pirkko J Pussinen; Juha Sinisalo
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

6.  Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis.

Authors:  Qing-Jun Zhang; Tram Anh T Tran; Ming Wang; Mark J Ranek; Kristen M Kokkonen-Simon; Jason Gao; Xiang Luo; Wei Tan; Viktoriia Kyrychenko; Lan Liao; Jianming Xu; Joseph A Hill; Eric N Olson; David A Kass; Elisabeth D Martinez; Zhi-Ping Liu
Journal:  Nat Commun       Date:  2018-12-07       Impact factor: 17.694

7.  Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway.

Authors:  Yundou Wu; Peijun Song; Xinke Yuan; Dayong Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-21       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.